Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yossi Febriani"'
Autor:
Zaeema Naveed, Cherry Chu, Mina Tadrous, Areti-Angeliki Veroniki, Julia Li, Isabelle Rouleau, Yossi Febriani, Andrew Calzavara, Sarah A. Buchan, Sharifa Nasreen, Kevin L. Schwartz, James Wilton, Chi Yon Seo, Nisha Thampi, Sarah E. Wilson, Monika Naus, Gaston De Serres, Naveed Z. Janjua, Jeffrey C. Kwong
Publikováno v:
Heliyon, Vol 10, Iss 5, Pp e26551- (2024)
Objective: To compare myocarditis/pericarditis risk after COVID-19 mRNA vaccination versus SARS-CoV-2 infection, and to assess if myocarditis/pericarditis risk varies by vaccine dosing interval. Methods: In this retrospective cohort study, we used li
Externí odkaz:
https://doaj.org/article/ffe593189798424c8e8476c1bd051472
Autor:
Sharifa Nasreen, Yossi Febriani, Héctor Alexander Velásquez García, Geng Zhang, Mina Tadrous, Sarah A Buchan, Christiaan H Righolt, Salaheddin M Mahmud, Naveed Zafar Janjua, Mel Krajden, Gaston De Serres, Jeffrey C Kwong
Publikováno v:
Clinical Infectious Diseases. 76:640-648
Background A major goal of coronavirus disease 2019 (COVID-19) vaccination is to prevent severe outcomes (hospitalizations and deaths). We estimated the effectiveness of messenger RNA (mRNA) and ChAdOx1 COVID-19 vaccines against severe outcomes in 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fa5cff37968f72a8be5c9bf119948bf
https://doi.org/10.1093/cid/ciac634
https://doi.org/10.1093/cid/ciac634
Autor:
Sara Carazo, Danuta M. Skowronski, Marc Brisson, Chantal Sauvageau, Nicholas Brousseau, Judith Fafard, Rodica Gilca, Denis Talbot, Manale Ouakki, Yossi Febriani, Geneviève Deceuninck, Philippe De Wals, Gaston De Serres
BackgroundDue to severe outcomes, elderly adults 60 years or older are prioritized for COVID-19 vaccination but accumulated SARS-CoV-2 infection and vaccination likely modifies their risk. We estimated vaccine effectiveness against omicron-associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb4107634ceaa473d09383e05dea4c26
https://doi.org/10.1101/2022.12.21.22283740
https://doi.org/10.1101/2022.12.21.22283740
Autor:
Sharifa Nasreen, Yossi Febriani, Héctor Alexander Velásquez García, Geng Zhang, Mina Tadrous, Sarah A. Buchan, Christiaan H. Righolt, Salaheddin M. Mahmud, Naveed Zafar Janjua, Mel Krajden, Gaston De Serres, Jeffrey C. Kwong
BackgroundA major goal of COVID-19 vaccination is to prevent severe outcomes (hospitalizations and deaths). We estimated the effectiveness of mRNA and ChAdOx1 COVID-19 vaccines against severe outcomes in four Canadian provinces between December 2020
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d19466eb08c99e8b1fc740cd05ee549
https://doi.org/10.1101/2022.04.13.22273825
https://doi.org/10.1101/2022.04.13.22273825
Autor:
Danuta M Skowronski, Yossi Febriani, Manale Ouakki, Solmaz Setayeshgar, Shiraz El Adam, Macy Zou, Denis Talbot, Natalie Prystajecky, John R Tyson, Rodica Gilca, Nicholas Brousseau, Geneviève Deceuninck, Eleni Galanis, Chris D Fjell, Hind Sbihi, Elise Fortin, Sapha Barkati, Chantal Sauvageau, Monika Naus, David M Patrick, Bonnie Henry, Linda M N Hoang, Philippe De Wals, Christophe Garenc, Alex Carignan, Mélanie Drolet, Agatha N Jassem, Manish Sadarangani, Marc Brisson, Mel Krajden, Gaston De Serres
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 75(11)
Background The Canadian coronavirus disease 2019 (COVID-19) immunization strategy deferred second doses and allowed mixed schedules. We compared 2-dose vaccine effectiveness (VE) by vaccine type (mRNA and/or ChAdOx1), interval between doses, and time
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69e3ac8adecf9c21d8f5c4faba967b57
https://pubmed.ncbi.nlm.nih.gov/35438175
https://pubmed.ncbi.nlm.nih.gov/35438175
Autor:
Genevieve Deceuninck, Manish Sadarangani, Yossi Febriani, Philippe De Wals, Bonnie Henry, Solmaz Setayeshgar, Macy Zou, Marc Brisson, Hind Sbihi, Danuta M. Skowronski, Sapha Barkati, Manale Ouakki, Mel Krajden, Chantal Sauvageau, Élise Fortin, Chris D Fjell, Monika Naus, Natalie Prystajecky, Nicholas Brousseau, Rodica Gilca, Christophe Garenc, Mélanie Drolet, Alex Carignan, David M. Patrick, Linda Mn Hoang, Denis Talbot, John R Tyson, Eleni Galanis, Gaston De Serres
BackgroundThe Canadian COVID-19 immunization strategy deferred second doses and allowed mixed schedules. We compared two-dose vaccine effectiveness (VE) by vaccine type (mRNA and/or ChAdOx1), interval between doses, and time since second dose in two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38e88546ab8d2782039768babcad5266
https://doi.org/10.1101/2021.10.26.21265397
https://doi.org/10.1101/2021.10.26.21265397
Autor:
Suzanne Gingras, Patrick Levallois, Shannon E. Majowicz, Pierre Gosselin, Manon Fleury, Yossi Febriani
Publikováno v:
BMC Public Health
BMC Public Health, Vol 10, Iss 1, p 48 (2010)
BMC Public Health, Vol 10, Iss 1, p 48 (2010)
Background Increasing livestock density and animal manure spreading, along with climate factors such as heavy rainfall, may increase the risk of acute gastrointestinal illness (AGI). In this study we evaluated the association between farming activiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86dcbfb4caf8d6c36736ca010b5a07c5
http://europepmc.org/articles/PMC2834625
http://europepmc.org/articles/PMC2834625